David M Stack insider trades: Pacira BioSciences (PCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
78 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | PCRX | ↓ Sell | 10,384 | $38.41 | $399K | Direct | Jun 7, 2023 (0d) |
| Jun 8, 2022 | PCRX | ↓ Sell | 25,793 | $60.56 | $1.6M | Direct | Jun 8, 2022 (0d) |
| Jun 4, 2021 | PCRX | ↓ Sell | 14,905 | $61.04 | $910K | Direct | Jun 8, 2021 (4d) |
| Jun 4, 2021 | AMRN | ↑ Buy | 15,000 | $4.56 | $68K | Indirect | Jun 7, 2021 (3d) |
| May 12, 2021 | PCRX | ↓ Sell | 42,500 | $61.44 | $2.6M | Direct | May 13, 2021 (1d) |
| Feb 3, 2021 | PCRX | ↓ Sell | 42,500 | $70.31 | $3.0M | Direct | Feb 4, 2021 (1d) |
| Nov 30, 2020 | AMRN | ↑ Buy | 25,000 | $4.86 | $122K | Indirect | Dec 2, 2020 (2d) |
| Nov 30, 2020 | CHMA | ↑ Buy | 25,000 | $4.27 | $107K | Indirect | Dec 1, 2020 (1d) |
| Oct 16, 2020 | PCRX | ↓ Sell | 90,000 | $55.36 | $5.0M | Direct | Oct 16, 2020 (0d) |
| Aug 17, 2020 | PCRX | ↓ Sell | 15,000 | $61.91 | $929K | Direct | Aug 19, 2020 (2d) |
| Jul 15, 2020 | PCRX | ↓ Sell | 12,000 | $56.88 | $683K | Direct | Jul 17, 2020 (2d) |
| Jun 8, 2020 | PCRX | ↓ Sell | 31,425 | $47.31 | $1.5M | Direct | Jun 8, 2020 (0d) |
| Jan 15, 2020 | PCRX | ↓ Sell | 25,000 | $42.68 | $1.1M | By LCK Investment LLC | Jan 17, 2020 (2d) |
| Nov 15, 2019 | PCRX | ↓ Sell | 45,000 | $42.81 | $1.9M | Direct | Nov 19, 2019 (4d) |
| Nov 15, 2019 | PCRX | ↓ Sell | 25,000 | $42.81 | $1.1M | By LCK Investment LLC | Nov 19, 2019 (4d) |
| Aug 15, 2019 | PCRX | ↓ Sell | 12,849 | $39.15 | $503K | Direct | Aug 16, 2019 (1d) |
| Jul 11, 2019 | AMRN | ↓ Sell | 51,991 | $22.28 | $1.2M | By David M. Stack Family Trust | Jul 12, 2019 (1d) |
| Jul 8, 2019 | PCRX | ↓ Sell | 13,115 | $42.88 | $562K | Direct | Jul 10, 2019 (2d) |
| Jun 4, 2019 | PCRX | ↓ Sell | 12,385 | $42.91 | $531K | Direct | Jun 6, 2019 (2d) |
| May 29, 2019 | AMRN | ↓ Sell | 33,799 | $18.45 | $624K | Direct | May 31, 2019 (2d) |
| May 17, 2019 | AMRN | ↓ Sell | 13,174 | $18.00 | $237K | Direct | May 21, 2019 (4d) |
| Jan 10, 2019 | AMRN | ↓ Sell | 98,572 | $18.00 | $1.8M | By David M. Stack Family Trust | Jan 11, 2019 (1d) |
| Jan 10, 2019 | AMRN | ↓ Sell | 26,932 | $18.00 | $485K | Direct | Jan 11, 2019 (1d) |
| Nov 15, 2018 | PCRX | ↓ Sell | 15,000 | $47.39 | $711K | Direct | Nov 19, 2018 (4d) |
| Aug 15, 2018 | PCRX | ↓ Sell | 33,062 | $47.32 | $1.6M | Direct | Aug 16, 2018 (1d) |
| Jun 7, 2018 | PCRX | ↓ Sell | 18,406 | $36.28 | $668K | Direct | Jun 8, 2018 (1d) |
| May 15, 2018 | PCRX | ↓ Sell | 25,000 | $33.79 | $845K | Direct | May 17, 2018 (2d) |
| Jan 10, 2018 | PCRX | ↓ Sell | 28,885 | $40.19 | $1.2M | Direct | Jan 12, 2018 (2d) |
| Nov 15, 2017 | PCRX | ↓ Sell | 58,885 | $38.34 | $2.3M | Direct | Nov 17, 2017 (2d) |
| Aug 15, 2017 | PCRX | ↓ Sell | 28,885 | $36.37 | $1.1M | Direct | Aug 17, 2017 (2d) |
| Jun 5, 2017 | PCRX | ↓ Sell | 4,311 | $43.32 | $187K | Direct | Jun 7, 2017 (2d) |
| Jan 17, 2017 | PCRX | ↓ Sell | 15,000 | $38.41 | $576K | Direct | Jan 19, 2017 (2d) |
| Nov 15, 2016 | PCRX | ↓ Sell | 15,000 | $37.28 | $559K | Direct | Nov 17, 2016 (2d) |
| Aug 15, 2016 | PCRX | ↓ Sell | 15,000 | $45.32 | $680K | Direct | Aug 17, 2016 (2d) |
| Apr 15, 2016 | PCRX | ↓ Sell | 25,000 | $64.14 | $1.6M | Direct | Apr 19, 2016 (4d) |
| Jan 15, 2016 | PCRX | ↓ Sell | 15,000 | $63.84 | $958K | Direct | Jan 19, 2016 (4d) |
| Oct 15, 2015 | PCRX | ↓ Sell | 15,000 | $37.57 | $564K | Direct | Oct 19, 2015 (4d) |
| Jul 15, 2015 | PCRX | ↓ Sell | 15,000 | $67.78 | $1.0M | Direct | Jul 17, 2015 (2d) |
| Apr 15, 2015 | PCRX | ↓ Sell | 25,000 | $90.50 | $2.3M | Direct | Apr 17, 2015 (2d) |
| Jan 15, 2015 | PCRX | ↓ Sell | 15,000 | $97.52 | $1.5M | Direct | Jan 20, 2015 (5d) |
| Oct 15, 2014 | PCRX | ↓ Sell | 15,000 | $99.49 | $1.5M | Direct | Oct 17, 2014 (2d) |
| Jul 15, 2014 | PCRX | ↓ Sell | 15,000 | $86.75 | $1.3M | Direct | Jul 16, 2014 (1d) |
| May 9, 2014 | PCRX | ↓ Sell | 25,000 | $73.94 | $1.8M | Direct | May 9, 2014 (0d) |
| Dec 30, 2013 | PCRX | ↓ Sell | 15,000 | $55.84 | $838K | Direct | Jan 2, 2014 (3d) |
| Sep 30, 2013 | PCRX | ↓ Sell | 15,000 | $47.05 | $706K | Direct | Oct 2, 2013 (2d) |
| Jun 28, 2013 | PCRX | ↓ Sell | 15,000 | $28.73 | $431K | Direct | Jul 2, 2013 (4d) |
| Mar 28, 2013 | PCRX | ↓ Sell | 15,000 | $28.66 | $430K | Direct | Apr 1, 2013 (4d) |
| Feb 10, 2011 | PCRX | ↑ Buy | 5,000 | $6.60 | $33K | Direct | Feb 11, 2011 (1d) |
| Mar 16, 2009 | BITI | ↑ Buy | 1,500 | $3.43 | $5K | Direct | Mar 17, 2009 (1d) |
| Mar 9, 2009 | BITI | ↑ Buy | 1,500 | $3.00 | $5K | Direct | Mar 11, 2009 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCRX insiders
Open-market trades in the last 12 months
About David M Stack's insider trades
David M Stack is CEO and Chairman at Pacira BioSciences (PCRX). Since Oct 30, 2006, David has reported 6 open-market purchases worth $339K and 72 sales worth $52.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
28 sales (1% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (66 filings), grants and awards (37 filings), gifts (3 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.